Juvenescence News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Juvenescence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Juvenescence Today - Breaking & Trending Today
/PRNewswire/ Juvenescence Limited ("Juvenescence"), through its JuvLife Division, joins the 200M Fund portfolio, managed by Banco Português de Fomento, in. ....
/PRNewswire/ Juvenescence Limited ("Juvenescence") and the Buck Institute for Research on Aging (the "Buck") announce a new joint venture with the formation. ....
Findings are expected to inform portfolio company's innovative approach to Regenerative Medicine Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study ....
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog). ....
Juvenescence Limited: Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer Dr. Grazia Piizzi, PhD, has joined its Executive Management Team as Chief Scientific Officer. Juvenescence is based on a new understanding of the underlying biological causes of aging, creating evidence-based and science-backed therapies. It is focused on increasing how long people live in health by preventing the diseases of aging in the ?rst place. The Juvenescence team includes highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in the pharmaceutical and consumer health sectors. Dr. Piizzi has more than 15 years of experience in the global pharmaceutical and biotech industry. Most recently, she was the SVP of Small Molecules R&D and Head of Inflammation at a Flagship Pioneering startup, Cygnal Therapeutics, decoding the links between peripheral neurons and diseases (2019-2021). Previously, she held the position of ....